Geron Corp (GERN)

May 9, 2025, 8:28 AM EDT - 5 days ago

Geron: Rytelo's Limited Adoption And Flat Demand Signal Troubled Outlook (Rating Downgrade)

May 8, 2025, 11:24 PM EDT - 5 days ago

GERN Investors Have Opportunity to Join Geron Corporation Fraud Investigation with the Schall Law Firm

May 7, 2025, 12:50 PM EDT - 7 days ago

Geron Corporation (GERN) Q1 2025 Earnings Call Transcript

May 7, 2025, 12:33 PM EDT - 7 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 12, 2025 in Geron Lawsuit – GERN

May 7, 2025, 7:00 AM EDT - 7 days ago

Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights

Apr 24, 2025, 9:33 PM EDT - 19 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

Apr 18, 2025, 4:30 PM EDT - 26 days ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 9, 2025, 10:40 AM EDT - 5 weeks ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

Mar 31, 2025, 4:32 PM EDT - 6 weeks ago

Geron Corp.: A Compelling Potential Buying Opportunity Thanks To Bearish Comments

Mar 31, 2025, 4:30 PM EDT - 6 weeks ago

Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025

Mar 31, 2025, 2:34 PM EDT - 6 weeks ago

Biotech Stocks Q1 2025 Recap: Winners And Underperformers

CMRX CRVO CVS LLY NVO SEPN

Mar 22, 2025, 12:31 PM EDT - 7 weeks ago

Lifshitz Law PLLC Announces Investigations of Geron Corporation (NASDAQ: GERN), and The Bancorp, Inc. (NASDAQ: TBBK)

TBBK

Mar 17, 2025, 5:19 PM EDT - 2 months ago

Geron Corp: How Concerned Should We Be About Rytelo Sales?

Mar 17, 2025, 7:42 AM EDT - 2 months ago

GERN Investors Have Opportunity to Lead the Geron Corporation Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - GERN

Mar 14, 2025, 3:04 PM EDT - 2 months ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Geron Corporation (GERN)

Mar 11, 2025, 4:30 PM EDT - 2 months ago

Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS

Mar 11, 2025, 4:02 PM EDT - 2 months ago

Geron Corporation Announces Departure of Chief Executive Officer

Feb 26, 2025, 12:12 PM EST - 2 months ago

Geron: Rytelo's Market Share Concerns Justified As 3L Dominates Early Sales

Feb 26, 2025, 11:31 AM EST - 2 months ago

Geron Corporation (GERN) Q4 2024 Earnings Call Transcript